Apr
23

Drug Trends in Workers Comp

Workers comp PBM and medical services company PMSI released its annual Drug Trends Report at RIMS earlier this week. I noted a couple highlights in an earlier post; you can download a copy here.
One of the more notable findings is the increase in the rate of inflation in drug costs, this coming after several years of decreasing inflation rates. A key contributor was per-script price increases which amounted to 6.1% in 2008.
There’s lots of good information in the Report, and you can’t beat the price.
My firm will be conducting the Sixth Annual Survey of Prescription Drug Management in Workers Comp next month; this survey focuses on tools and techniques employed to manage costs as well as payer executives’ views on cost drivers and PBMs.
For the fourth consecutive year the Survey is sponsored by Cypress Care.
Send an email to infoAThealthstrategyassocDOTcom if you’d like a copy of the report.


Apr
22

Coventry’s bill review program – CORRECTION

In my post earlier this week that mentioned developments with Coventry’s bill review services, I incorrectly stated:
Reports are that Coventry will ‘own’ the bill review application source code and related assets as of October 1 2009; what they will do then appears to be up in the air.
Well, that’s not exactly incorrect, as Coventry will own the application after that date, but sources indicate they already own it.
The significance of the 10/1/2009 date is that It marks the day that EDS will no longer support the application. EDS has provided IT support for BR 4.0 and the previous iterations of the program for years; as of October 1 they no longer will.
Which leads rather quickly to the next question – who will?
My assumption is Coventry. However, as I’m all too familiar with what happens when you make assumptions, I’ve reached out to Coventry and asked them what their plans are.
I’m not sanguine about the chances of a response.


Apr
21

RIMS – the first day

RIMS is in Orlando this year, a rather ironic location. The P&C insurance industry is in a bit of a fantasy world these days, with increasing reports of reserve inadequacy (anecdotal to be sure) while the soft market continues with few signs of firming pricing.
Monday was a bit of a blur; back to back meetings in the exhibit hall, interspersed with the inevitable encounters with old friends and colleagues passing on the latest news about who’s moved where and what deals are in the works.
The private equity folks are here as well, scouting for promising companies they can buy and use as a ‘platform’ to build a bigger company. There’s talk of several potential deals in the works – more on those as they develop.
The conference itself looks to be rather sparsely attended. Exhibit hall traffic is noticeably light, and few sessions are filled. This is likely due to a combination of the ‘AIG hangover’; big insurance companies are reluctant to send lots of folks to nice destinations (yes, some do think of Orlando as a ‘nice’ destination); the continuing soft market and financial impact thereof (more than a few insurers and vendors have recently laid off staff); and the lack of solid, new information delivered at the conference itself.
I’m using twitter to post brief comments/observations throughout the day – for updates sign up for my feed (Paduda). Here are a few quick takes from Monday.
The PBM world is consolidating at the top, and growing at the lower end. Some of the newer entrants are seeking to carve out niches based on clinical expertise in pain management (MyMatrixx), innovative pricing (PMOA), a focus on smaller payers (don’t use our name) or a push into the mid-tier (don’t use our name either).
There’s a lot of turmoil around Coventry Work Comp, with recent layoffs in their MSA division and in the IT support area (bill review specifically). Reports are that Coventry will ‘own’ the bill review application source code and related assets as of October 1 2009; what they will do then appears to be up in the air. While they would undoubtedly like to move all their payer clients over to BR 4.0 (their platform) from Ingenix’ PowerTrak (the system used by former Concentra clients) there is significant resistance to that move from PowerTrak users. That resistance, coupled with the expense of maintaining BR 4.0 and the recent layoff of BR support staff are clouding the crystal ball.
I’ll try once again to get a read from Coventry staff as to their strategy and direction; I don’t expect much as my repeated requests for information and dialogue have been met with silence. That’s too bad, as they have been and continue to be the dominant player in the comp managed care business, and their directional changes will dramatically impact their current – and potential – customers…


Apr
17

Workers comp bill review survey – initial highlights

I’m about half-way through the first annual Survey of Workers Compensation Bill Review, and already there are a few somewhat surprising findings. These are very preliminary, but nonetheless intriguing.
1. The range of pricing for payers using external bill review vendors is broader than I expected, even after accounting for differences in services provided and volume. The range is over four dollars per bill.
2. Payers’ views of bill review vendors are diverse, with some payers enthusiastic about a particular vendor and others disdainful.
3. A majority of respondents voiced concern about their vendor’s inability to keep up with fee schedule and regulatory changes, and the negative impact this has had on the payer.
4. Regarding the use of UCR databases, some respondents are quite concerned, while others (primarily ones who are not using the Ingenix MDR/PHCS databases) are much less concerned. All respondents are well aware of the issue.
5. Most respondents view bill review as unnecessarily complex, difficult, time-consuming and expensive. The perception is much more of the bill intake, triage, review, repricing, and transmittal processes should be automated, with far fewer bills requiring human intervention.
The survey final report will be completed in mid-May; non-respondents can request a public version of the report by sending an email to infoAThealthstrategyassocDOTcom (substitute symbols for CAPS).


Apr
16

Stratacare sold

Word in the industry is a majority interest in bill review company Stratacare has been sold to a California private equity firm. Stratacare had been in and out of the financing market for over a year, and reports are that the investment firm purchased a majority stake. Several sources report industry veteran Paul Glover is also involved in the deal.
Glover has a long history in the workers comp business, most recently concluding a stint as CEO of Interplan (which merged with the Parker Group in October of 2007). Glover then served on the board of the successor company, HealthSmart.
That’s all for now; details when they become available…


Apr
16

The ‘new’ approach to work comp pharmacy

Today we take a deep dive into the very tiny pool of workers comp pharmacy benefit management – where there’s a recent development worthy of note.
The latest iteration of factoring company Third Party Solutions recently unveiled their new marketing strategy – at least it’s new to parent Stone River.
Stone River Pharmacy Solutions (SRPS) is repeating a strategy employed in the past by previous owners of TPS and WorkingRx – partner with retail pharmacies while simultaneously selling itself as a pharmacy benefit manager.
The pharmacy partnership’s value proposition is straight forward; less paperwork, faster pay, fewer hassles for the retail shops if they’ll sell their work comp scripts to SRPS.
Here’s their pitch to pharmacies:
“The bottom line is your bottom line. StoneRiver Pharmacy Solutions helps you build your business by containing administrative costs, increasing revenue and therefore profits…”
No mystery who their customer is – the retail pharmacy. Nothing new there.
What is somewhat new, well, at least new to SRPS, is the boldness of their approach to employers and other work comp payers. Remember, these are the folks who have been driving up pharmacy costs, reducing network penetration, suing insurance companies and PBMs, hassling adjusters and employers for payment, and otherwise making payers’ lives miserable for years.
But all that’s changed…
Here’s how SRPS puts it…
“Helping employers and payors care for injured employees while managing and reducing pharmacy-related cost is more than our mission. It is a commitment we live daily by delivering our industry-leading solution in workers’ compensation pharmacy care management.
We Ask. We Listen. We Carefully Consider. We Deliver!”
There’s a logical disconnect here; on the same webpage, SRPS claims to deliver “improved revenue and profits” to retail pharmacies. How, pray tell, can a vendor increase a provider’s revenues and profits while reducing payers’ pharmacy-related costs?
Anyone?
There’s more.
“Despite participation in workers’ compensation prescription programs, many employers and payors fail to achieve anticipated cost savings. Injured worker’s routinely don’t know or fail to identify the pharmacy program through which to process their workers’ compensation prescriptions; therefore, the pharmacy uses a default billing service. Until now default billing services have been unable to apply financial or clinical controls to these prescriptions. Without these controls prescriptions are processed out-of-network and higher priced medications or medications unrelated to the patient’s injury are dispensed.”
Hmmm, perhaps the copywriters haven’t kept abreast of the latest information on drug trends in workers comp. In fact, the trend rate for pharmacy has decreased each year for the last five years, and was below 5% last year. This at a time when PBM penetration was growing dramatically, clinical management programs were starting to deliver real results, and payers were aggressively contesting third party biller business practices.
Oh, and SRPS’ predecessor organizations were claiming they could apply ‘clinical and financial controls’ to scripts years ago. What’s different now? Well, SRPS has cleared out all the old management, so perhaps they have some new whiz-bang process, or, more likely, they don’t have the benefit of knowing what was tried – and failed – in the past.
What does this mean for you?
You’ve got to admire their chutzpah. Just make sure to keep your hand on your wallet.


Apr
14

The latest on work comp drug costs

PMSI will be releasing their annual Drug Trends Report at RIMS in a couple weeks; they were kind enough to send a pre-release copy and give me permission to highlight a couple note-worthy items.
The lead story is cost. After moderating significantly in 2007, drug costs were up by over five percent in 2008, driven primarily by increased price. That is, while each injured worker got more drugs in 2008 than they received in 2007, most of the cost increase was driven by higher prices. But not for generics.
AWP, which remains the basis for drug unit pricing, went up over nine percent for brand drugs last year. (Generic inflation was negligible) With brand accounting for almost two-thirds of spend, the effect was rather significant in overall price inflation.
Interestingly, the introduction of new drugs had almost no impact on drug cost inflation in 2007 – but neither did the release of new generics.
There’s a lot more detail in the report, which should be available shortly. I’ll post a link as soon as it is.


Apr
14

Why PPO litigation is increasing

PPOs, or Preferred Provider Organizations, have been around for a couple dozen years. They are networks of credentialed (with varying degrees of rigor) doctors, hospitals, and ancillary providers that have agreed to provide lower rates for ‘members’ in return for some measure of exclusivity/promise that patients will be directed to use them. I’d note that this ‘promise’ is often not fulfilled, at least in the eye of the provider. That’s a whole separate issue, one we will likely get to in a future post.
As one good friend puts it, ‘PPOs are a box of contracts’, and not many PPO firms do much more than recruit, credential, negotiate, and contract.
Their popularity waxes and wanes, roughly in line with the underwriting cycle (as cost trends decrease, PPOs tend to grow, as cost trends increase, buyers seek more controlled networks and medical management systems).
Typically PPOs are owned by a large group health plan or specialty company such as a workers comp managed care firm. Many PPOs were built to market/sell to health plans and workers comp payers – Rockport, Coventry, and Interplan are examples of ‘vended PPOs’, as opposed to those built for the exclusive use of a healthplan.
The problem
There can be several issues with PPOs; lack of direction by the payer, inaccurate data, failure to maintain credentialing standards and ‘stacking’ are some of the more prevalent.
But of late another issue has been appearing more and more frequently – providers claiming they are not subject to a PPO contract and therefore should be reimbursed at U&C, or in the case of workers comp in many states, the state fee schedule.
Digging into the disagreements that arise when payers assert the providers are subject to a contracted discount, it looks like there are a few contributing factors.
First, some providers have contracts with many health plans and networks, and it canbe tough to keep them all straight. And, the PPO may have changed its name, merged with another firm, or been acquired since the original PPO contract was signed.
Those are the easy ones.
A knottier issue is caused by the mechanism of ‘provider selection’. When the provider’s bill comes into the healthplan/bill repricer, it is ‘checked’ against a database to determine if it is from a contracted, or participating, provider (known as a ‘par’ provider). This checking could occur either at the health plan/repricer, or the bills could be electronically sent to the PPO for the PPO to check par status and apply the discount.
What determines ‘par’ status is often the source of the problem. For example, PPOs want as many ‘hits’ as possible, so they err on the side of counting a provider as par if at all possible. The more hits, the more money they make (often), and the better they look to the payer. Payers like more hits because then the managed care folks can show the savings they deliver due to the discounts. So the payer side of the equation is motivated to use logic that assigns as many bills as possible to the par bucket.
To do that, payers often use a provider TIN (tax identification number) as the only criterion to determine par status. If a bill is from a provider with a TIN that matches some contract somewhere in the PPO company’s database, than the discount is taken. Payers may also use address, provider first name last name, and/or phone, but most try to use as few criteria as possible.
But large provider groups and hospitals and health systems often use the same TIN for many different service areas – outpatient surgery, inpatient, rehab, pharmacy, hospitalists, occupational medicine. And they rarely offer the same discount deal across all service types and locations. Some service types may not even participate due to the internal structure and demands of the health system.
Here’s real world example, provided by a consulting client. A bill from an occ med clinic hits a payer, who determines it is a par provider due solely to the TIN match. A 30% discount is taken, and the check cut. But the occ med clinic is not part of the original contract, which specifically states that discount is for inpatient medical services only.
The provider complains to the payer, who contacts the PPO, who eventually pulls the contract, says ‘oh, yeah, here’s the problem’, asks the occ med clinic to resubmit the bill, after which the bill may – or may not – be paid correctly.
Now multiply this by the hundreds, and it is easy to understand why some providers, fed up by the paperchase, are getting downright litigious. This leads to providers suing payers over a few dollars on an office visit – not to get those few dollars, but to force the payer to apply the correct repricing methodology.
If the PPO is the one doing the repricing (as is often the case), there is considerably less incentive to fix the problem. The PPO doesn’t have to handle all the calls (although in many cases they are involved at some level), figures many providers will not fight it as it isn’t worth it, and even if they do that’s a small price to pay for all those fees.
And that’s one major reason there’s so much litigation in the PPO world these days.


Apr
9

Could you just make a decision? Please??

TPAs and employers and insurance companies send out requests for proposal – to each other, to managed care firms, specialty providers, voc companies, IT providers, law firms. All have been on the receiving end of a voluminous, detailed, structured and rigorous RFP – so big that it clogs their virtual and/or physical mailbox.
The erstwhile vendor is initially happy. Hey, we made the cut, we’re on the list, we ‘get’ to respond. We have an opportunity.
Then the work starts. Even if the vendor is big, and has staff to help write the responses, and even if it has a ready-made library of canned responses, it is still a lot of work. We aren’t talking a couple hours here and there by a junior staff writer – every question has to be reviewed and assigned, then the answer checked for accuracy, grammar, and consistency with other answers. Then someone has to find all the reports and IT flow documents and disaster recovery plans and professional certifications and insurance coverage documents and CVs and make sure they have the right appendix numbers and are in the right format. Then it has to be collated, checked one more time, signed by an executive, and shipped out. All on the prospect’s schedule.
And that’s if it’s a big vendor; if it is a small company, the folks who are doing this work are also the folks who are supposed to be doing the ‘real’ work – handling the tasks that actually deliver value to customers and owners alike.
The point is there is a lot of work involved, and most of the vendors who are doing the work are not going to get anything out of it – at least in terms of revenue. No, they’re going to have to savor the joys of a job well done, even if not done well enough to actually win the business.
I know, the ‘customer’ has also put a lot of work into the process – no argument there. Just understanding what it is you want, what restrictions exist, what the timeline should be and who should be involved in the process from initial specs to final decision means meetings on top of meetings.
But just for a minute think about it from the vendors’ perspective. We’ll take your perspective on tomorrow.
The erstwhile vendors want to deliver for your company, they think they can do a better job of anyone else, yet they’re forced to only answer what they’re asked, not allowed to demonstrate their abilities and insights and expertise and knowledge. Yes, they may be able to – in response to the “is there anything else we should know, or other ideas you have”. But the responses to these questions don’t fit the scoring methodology. Even if they are creative and innovative and fresh, and look promising, it’s tough for them to see the light of day in the typical RFP process.
Now comes the waiting…and the waiting…and the waiting…
Sure, there’s a deadline. But more often than not, the deadline comes and goes, unmarked by the award, or announcement of a potential award. Instead, there’s news that the prospect needs more time to review the proposals, or more information has come in, or…
At the risk of being accused of unfairness, ask yourself – how often has an RFP process ended when it was supposed to, with a decision made, vendor selected, and losers notified, according to the original timetable?
I’ll go out on a very solid limb and say the answer is ‘not very often’.
Let me suggest this. The more a prospective customer delays the decision, the less credibility it will have, and the less willing potential vendors will be when the next RFP comes out. Some decisions are seemingly never made, until the queries from once-hopeful vendors trickle away.
If and when the award is announced, those potential customers who are willing to have the tough conversation with losers – despite what their lawyers say – are doing the right thing. This is a small world, and treating losing vendors professionally is just the right thing to do. It will also make them better when next they respond to the ‘customer’s’ RFP.
It is also a recognition of the work invested by all vendors, not just the winner. It provides the losing vendor with valuable input and knowledge, and delivers at least some return on all that effort.
What does this mean for you?
Do unto others.


Apr
8

Why your hospital costs are going up

There’s little doubt hospital reimbursement methodology is going to change dramatically over the next few years.
We’re going to see a shift from fee for service to global episodic reimbursement, a shift that has already begun. I’ll get into that next week, but for now, there’s increasing evidence that private payers’ hospital costs are rising in large part due to several recent changes in reimbursement policies.
Over the last year, there have been three major changes in hospital reimbursement: the implementation of MS-DRGs (increase in the number of DRGs to better account for patient severity); a 4.8% cut in Medicare hospital reimbursement spread over three years; and the decision by the Centers for Medicare and Medicaid Services (CMS) to stop paying for ‘never ever’ events – conditions that are egregious medical errors requiring medical treatment.
The net result of these changes has been a drop in governmental payments to hospitals, the decision by several major commercial payers to not pay for never-evers, and increased cost-shifting from hospitals to private payers.
The implementation of MS DRGs and the accompanying decrease in reimbursement looks to be the most significant of the changes, and is already having a dramatic impact on hospital behavior patterns. By adding more DRG codes, CMS is acknowledging there are different levels of patient acuity – that performing a quadruple bypass on an otherwise-healthy patient takes fewer resources than doing the same operation on an obese patient with diabetes and hypertension. While these different levels were somewhat factored in to the ‘old’ DRG methodology, the new MS-DRGs better tie actual costs to reimbursement. (for a more detailed discussion, see here)
Here’s one example.
CMS projected that these changes would reduce Medicare’s total reimbursement for cardiovascular surgery by about $620 million, while orthopedic surgeries are projected to see an increase in reimbursement of almost $600 million.
Orthopedic reimbursement is increasing because there are now more MS DRGs for orthopedic surgery, and the additional DRGs will likely mean hospitals will be able to get paid more in 2009 and beyond than they were last year.
Hospitals are going to work very hard to get more orthopedic patients in their ORs, and they are going to carefully examine these patients to make sure they uncover every complication and comorbidity – because a ‘sicker’ patient equals higher reimbursement.
What does this mean for private payers?
Orthopedic costs will likely rise because hospitals will get better at allocating costs. But cardiovascular costs will also increase due to cost shifting.
Heads they win, tails you lose.